Ling, S. and Dou, X. (2025) “Real–world Experience with JAK Inhibitors and Dupilumab in Dystrophic Epidermolysis Bullosa: A Case Report and Literature Review”, Acta Dermato-Venereologica, 105, p. adv43588. doi: 10.2340/actadv.v105.43588.